HCM is a genetic disease, usually caused by mutations in sarcomere proteins such as myosin, actin, tropomyosin, and myosin-binding protein C.

Professor Lisa Volpatti developed a targeted approach that directs anti-inflammatory proteins to diseased arteries, reducing ...

This list brings together experts whose work spans early detection, artificial intelligence, pediatric heart surgery and ...

Objective Multidisciplinary team (MDT) meetings are central to treatment decisions in aortic stenosis (AS), particularly for borderline or high-risk patients. This study evaluates long-term, ...

Aortic stenosis (AS) is a progressive heart valve disease that leads to the narrowing of the aortic valve opening, restricting blood flow from the heart to the rest of the body.

Background Aortic valve calcification (AVC) is a disease process driven by inflammation and lipid infiltration, serving as a ...

Khaberni - The field of heart diseases is undergoing rapid scientific transformations that are no longer measured by a ...

In a consensus statement issued by the European Renal Association and published online Nov. 28 in Nephrology Dialysis ...

Researchers at the NIH and Emory School of Medicine have completed the first minimally invasive coronary artery bypass of the ...

In addition, Anteris today announced the closing of its previously announced sale, in a private placement (the “Private Placement”), of 15,652,173 shares of common stock to Medtronic plc (through a ...

A federal judge has paused the merger of the only two companies developing a heart device made for high-risk patients suffering from ...

Medtronic will invest $90M in Anteris Technologies for DurAVR TAVR device development, contingent on a $200M IPO.